By contrast, the TGF-β producing NK cell we have induced in vivo with CD2 targeted NPs containing IL-2 harvested 5 weeks after NP administration protected lupus mice from renal disease.2 The gene discussed is TGFB1; the disease is systemic lupus erythematosus.